Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study

M Javle1, J Yu, C Garrett

  • 1Department of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA. mjavle@mdanderson.org